| | | | | | | | | | |
|
|
|
|
| Dockets Entered
On May 10, 2005
Table of Contents
|
|
|
|
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
|
|
| 1990S-0308
|
| Generic Drug Speeches & Policy and Procedure Guides
|
|
|
|
|
| 1998P-0151
|
| Introduction Of Downed Cattle Into The Food Supply
|
|
|
|
|
| 1999P-1340
|
| Declared Eternity eau de Parfum Misbranded
|
|
|
|
|
| 2000N-0504
|
| Egg Safety Action Plan
|
|
|
|
|
| 2000N-1571
|
| Enrofloxacin for Poultry: Opportunity for Hearing
|
|
|
|
|
| 2000P-1439
|
| Iceberg Water Deviating From Identity Standard
|
|
|
|
|
| 2001P-0075
|
| Switch Status of Emergency Contraceptives from Rx to OTC
|
|
|
|
|
| 2001P-0230
|
| Domestic Marketing & Importation of Transgenic Fish
|
|
|
|
|
| 2002P-0317
|
| Recall Aspartame as a Neurotoxic Drug
|
|
|
|
|
| 2003N-0076
|
| Food Labeling: Trans Fatty Acids in Nutrition Labeling; Consumer research to consider possible footnote statements
|
|
|
|
|
| 2004N-0432
|
| Radioactive Drugs for Certain Research Uses; Public Meeting
|
|
|
|
|
| 2004N-0454
|
| Dietary Supplements; Premarket Notification for New Dietary Ingredient Notifications; Public Meeting
|
|
|
|
|
| 2004N-0456
|
| Serving Sizes of Products that Can Reasonably be Consumed at One Eating Occasion; Updating of Reference Amounts Customarily Consumed; Approaches for Recommending Smaller Portion Sizes
|
|
|
|
|
|
|
|
|
| 2004N-0463
|
| Food Labeling: Prominence of Calories
|
|
|
|
|
| 2004N-0527
|
| Medical Devices; Medical Device Reporting
|
|
|
|
|
| 2004N-0559
|
| Overall benefit to risk considerations for Cox-2 selective nonsteroidal anti-inflammatory drugs and related agents
|
|
|
|
|
| 2004P-0452
|
| Regulate the use of coding on food labels
|
|
|
|
|
| 2004Q-0151
|
| Qualified Health Claim (QHC): soy protein and cancer
|
|
|
|
|
| 2005D-0062
|
| Draft Guidance FDAs Drug Watch for Emerging Drug Safety
|
|
|
|
|
| 2005N-0012
|
| Agency Information Collection Activities: Proposed Collection; Comment Request; Allergen Labeling of Food Products Consumer Preference Survey and Experimental Study on Allergen Labeling of Food Produc
|
|
|
|
|
|
|
|
|
| 2005N-0147
|
| Sprout Safety Public Meeting
|
|
|
|
|
| 2005P-0020
|
| replace inacurate and/or misleading wording as unpasteurized and replace with the word untreated
|
|
|
|
|
| 2005P-0176
|
| make a determination that Cefditoren Pivoxil tablets, 400 mg is suitable for submission in an ANDA
|
|
|
|
|
| 2005V-0177
|
| Projector for a Laser Light Show
|
|
|
|
|
| 1990S-0308
|
| Generic Drug Speeches & Policy and Procedure Guides
|
|
|
|
|
| M
748
|
| Statistical Report - Month of September 2004
|
| Vol #:
|
| 53
|
|
|
|
|
| M
749
|
| Statistical Report - Month of October 2004
|
| Vol #:
|
| 54
|
|
|
|
|
| M
750
|
| Statistical Report - Month of November 2004
|
| Vol #:
|
| 54
|
|
|
|
|
| M
751
|
| Statistical Report - Month of January 2005
|
| Vol #:
|
| 54
|
|
|
|
|
| M
752
|
| Statistical Report - Month of February 2005
|
| Vol #:
|
| 43
|
|
|
|
|
| M
753
|
| Statistical Report - Month of March 2005
|
| Vol #:
|
| 54
|
|
|
|
|
| 1998P-0151
|
| Introduction Of Downed Cattle Into The Food Supply
|
|
|
|
|
| EMC 4324
|
| S. Sudduth
|
| Vol #:
|
| 320
|
|
|
|
|
| EMC 4325
|
| A. Ashton
|
| Vol #:
|
| 320
|
|
| | | | | | | | |
|
|
|
|
| EMC 4326
|
| B. Hunter
|
| Vol #:
|
| 320
|
|
|
|
|
| EMC 4327
|
| K. Whiteman
|
| Vol #:
|
| 320
|
|
|
|
|
| EMC 4328
|
| K. Crupi
|
| Vol #:
|
| 320
|
|
|
|
|
| EMC 4329
|
| M. Rammelkamp
|
| Vol #:
|
| 320
|
|
|
|
|
| EMC 4330
|
| B. Eddington
|
| Vol #:
|
| 320
|
|
|
|
|
| 1999P-1340
|
| Declared Eternity eau de Parfum Misbranded
|
|
|
|
|
| EMC 601
|
| K. Courneen
|
| Vol #:
|
| 24
|
|
|
|
|
| 2000N-0504
|
| Egg Safety Action Plan
|
|
|
|
|
| N
1
|
| FDA
|
| Vol #:
|
| 32
|
|
|
|
|
| 2000N-1571
|
| Enrofloxacin for Poultry: Opportunity for Hearing
|
|
|
|
|
| EXB 1201
|
| Bayer Corporation
|
| Vol #:
|
| 454
|
|
|
|
|
| 2000P-1439
|
| Iceberg Water Deviating From Identity Standard
|
|
|
|
|
| N
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
|
|
| 2001P-0075
|
| Switch Status of Emergency Contraceptives from Rx to OTC
|
|
|
| EMC 14426
|
| M. Leslie
|
| Vol #:
|
| 342
|
|
|
|
|
| EMC 14427
|
| J. Coppock
|
| Vol #:
|
| 342
|
|
|
|
|
| EMC 14428
|
| H. Ehrenreich
|
| Vol #:
|
| 342
|
|
|
|
|
| 2001P-0230
|
| Domestic Marketing & Importation of Transgenic Fish
|
|
|
|
|
| EMC 3168
|
| E. Witham
|
| Vol #:
|
| 261
|
|
|
|
|
| 2002P-0317
|
| Recall Aspartame as a Neurotoxic Drug
|
|
|
|
|
| EMC 457
|
| T. McClain
|
| Vol #:
|
| 7
|
|
|
|
|
| 2003N-0076
|
| Food Labeling: Trans Fatty Acids in Nutrition Labeling; Consumer research to consider possible footnote statements
|
|
|
|
|
| EMC 780
|
| L. Kelley
|
| Vol #:
|
| 11
|
|
|
|
|
| EMC 781
|
| P. Kelly
|
| Vol #:
|
| 11
|
|
|
|
|
| EMC 782
|
| K. Boyko
|
| Vol #:
|
| 11
|
|
|
|
|
| EMC 783
|
| M. Brinson
|
| Vol #:
|
| 11
|
|
|
|
|
| EMC 784
|
| M. Hall
|
| Vol #:
|
| 11
|
|
|
|
|
| EMC 785
|
| No signature
|
| Vol #:
|
| 11
|
|
|
|
|
| 2004N-0432
|
| Radioactive Drugs for Certain Research Uses; Public Meeting
|
|
|
|
|
| N
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
|
|
| 2004N-0454
|
| Dietary Supplements; Premarket Notification for New Dietary Ingredient Notifications; Public Meeting
|
|
| | | | | | | | |
|
| |
|
| 2004Q-0151
|
| Qualified Health Claim (QHC): soy protein and cancer
|
|
|
|
|
| C 102
|
| M. S. Luskey
|
| Vol #:
|
| 9
|
|
|
|
|
| 2005D-0062
|
| Draft Guidance FDAs Drug Watch for Emerging Drug Safety
|
|
|
|
|
| GDL
1
|
| Guidance
|
| Vol #:
|
| 1
|
|
|
|
|
| NAD
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
|
|
| 2005N-0012
|
| Agency Information Collection Activities: Proposed Collection; Comment Request; Allergen Labeling of Food Products Consumer Preference Survey and Experimental Study on Allergen Labeling of Food Produc
|
|
|
|
|
|
|
|
|
|
|
| N
2
|
| FDA
|
| Vol #:
|
| 2
|
|
|
|
|
| 2005N-0147
|
| Sprout Safety Public Meeting
|
|
|
| EMC 1
|
| Dr. E. Ryser
|
| Vol #:
|
| 1
|
|
|
|
|
| EMC 2
|
| K. Warriner
|
| Vol #:
|
| 1
|
|
|
|
|
| 2005P-0020
|
| replace inacurate and/or misleading wording as unpasteurized and replace with the word untreated
|
|
|
|
|
| EMC 1
|
| R. Germond
|
| Vol #:
|
| 1
|
|
|
|
|
| 2005P-0176
|
| make a determination that Cefditoren Pivoxil tablets, 400 mg is suitable for submission in an ANDA
|
|
|
|
|
| ACK
1
|
| HFA-305 to Lachman Consultant Services, Inc.
|
| Vol #:
|
| 1
|
|
|
|
|
| 2005V-0177
|
| Projector for a Laser Light Show
|
|
|
|
|
| ACK
1
|
| HFA-305 to Club Miami
|
| Vol #:
|
| 1
|
|
|
|
|
| VAR
1
|
| Club Miami
|
| Vol #:
|
| 1
|
|
